Homogeneous Buccal Leukoplakia in Tobacco-smoking Patients
Keywords:
buccal leukoplakia, smoking, dysplasia.Abstract
Introduction: Leukoplakia is the most common potentially malignant lesion of the buccal mucosa; tobacco use is the main etiological factor; different degrees of epithelial dysplasia are present. Its study allows a better understanding of the clinical and histopathological manifestations of this disease.
Objective: To clinically and histopathologically characterize homogeneous buccal leukoplakia in patients who smoke tobacco.
Methods: A descriptive and cross-sectional study was performed. The universe was composed of 75 patients who smoked tobacco and cigars, attended in the stomatological consultation of the Specialties Polyclinic of the Clinical-Surgical Hospital Saturnino Lora Torres of Santiago de Cuba. By means of clinical and histopathological examination, homogeneous buccal leukoplakia was diagnosed. For the collection of the primary data, a model was made with the following variables: age group, sex, clinical diagnosis, time in smoking habit, anatomical location and histopathological study of the disease.
Results: Male sex (58.6%) and age group 60 years and older (41.3%) prevailed in the casuistry; hyperkeratosis (64.0%), mild chronic inflammatory infiltrate (60.0%) and mild epithelial dysplasia (73.3%) were the most common histopathological alterations in smokers aged 21 years and older. Hyperchromasia of the nucleus (100.0%) and nuclear pleomorphism (96.80%) were the most prominent cellular changes. Interpapillary nail alterations (92.0%), stratum basale hyperplasia (88.9%) and loss of polarity (87.3%) resulted the most significant tissue dysplastic signs in buccal leukoplakia and cheek mucosa (40.0%) the anatomical site of highest occurrence of lesions.
Conclusions: All tobacco and cigarette smoking patients presented, clinically, buccal leukoplastic lesions, confirmed by histopathological study; male sex and the 60 and older age group are the most affected. Hyperparapokeratosis, mild chronic inflammatory infiltrate and mild epithelial dysplasia were the most predominant; hyperchromasia of the nucleus and nuclear pleomorphism were the most prominent cellular changes. In the epithelial dysplastic tissue, interpapillary nail alterations, hyperplasia of the stratum basale and loss of polarity prevailed and the most affected site, the cheek mucosa.
Downloads
References
González-Moles MA, González-Ruíz L. Leucoplasia oral, una revisión de los aspectos esenciales de su diagnóstico y tratamiento. Actual Med. 2018;103(803):44-6. DOI: https://doi.org/10.15568/am.2018.803.ao01
Castelnaux-Martínez M, Montoya-Sánchez I, Serguera-Batista Y, Giraldo-Moran R, Pérez-Rosabal A. Caracterización clínica y epidemiológica de pacientes con leucoplasia bucal. MEDISAN. 2020 [acceso 04/9/2022];24(1):[aprox.11 p.]. Disponible en: http://scielo.sld.cu/scielo.php?script=sci_arttext&pid=S1029-30192020000100004&lng=es.
Serrano-Hernández D, Riverón-Pupo R, Peña-Leyva CM, Laplace-Pérez B, Páez-González Y. Leucoplasia bucal, lesión potencialmente maligna para el cáncer de cabeza y cuello. HolCien. 2020 [acceso 04/9/2022];1(1):[aprox. 21 p.]. Disponible en: http://www.revholcien.sld.cu/index.php/holcien/article/view/8
Llanes Torres M, Díaz Rojas PA, Pérez Rumbaut GI, Crespo Lechuga GA, Naranjo Hernández L, Mesa Montero ZT. Parámetros histomorfométricos de la mucosa bucal en pacientes portadores de leucoplasia con displasia epitelial. Rev Finlay. 2022 [acceso 04/09/2022];12(2):151-9. Disponible en: http://scielo.sld.cu/scielo.php?script=sci-arttext&pid=S2221-24342022000200151&lng=es
Renda-Valera L, Cruz-Borjas Y, Parejo-Maden D, Cuenca-Garcell K. Nivel de conocimientos sobre el tabaquismo y su relación con la cavidad bucal. Rev Cub Med Mil. 2020 [acceso 04/09/2022];49(1):41-56 Disponible en: http://www.revmedmilitar.sld.cu/index.php/mil/article/view/280
Kumari P, Debta P, Dixit A. Oral Potentially Malignant Disorders: Etiology, Pathogenesis, and transformation into Oral Cancer. Front Pharmacol. 2022;20(13):[aprox.78p.]. DOI: https://doi.org/10.3389/fphar.2022.825266
Mortazavi H, Safi Y, Baharvand M, Jafari S, Anbari F, Rahmani S. Oral white lesions: an updated clinical diagnostic decision tree. Dent J (Basel). 2019;7(1):[aprox. 36 p.]. DOI: https://doi.org/10.3390/dj7010015
Milanés-Chalet A, Rogert-Alcolea I, Pérez-Milán A, Palomino-Rodríguez K, Beatón-Sablón A. Factores de riesgo asociados con leucoplasia bucal en pacientes del consultorio 43, Ciro Redondo, Bayamo. 2017. MULTIMED. 2018 [acceso 04/09/2022];22(2):365-71. Disponible en: http://revmultimed.sld.cu/index.php/ mtm/article/view/839
García-Molina Y, González-Lara M, Crespo-Morales A. Lesiones premalignas y malignas en el complejo bucal en La Palma. Rev Cienc Med Pinar Río. 2018 [acceso 04/09/2022];22(6):1059-68. Disponible en: http://revcmpinar.sld.cu/index.php/ publicaciones/article/view/355
Guerrero-Brito M, Pérez-Cabrera D, Hernández-Abreu NM. Lesiones bucales premalignas en pacientes con hábito de fumar. Medicentro Electrónica. 2020 [acceso 04/09/2022];24(1):159-64. Disponible en: http://scielo.sld.cu/scielo.php?script=sci_arttext&pid=S1029-30432020000100159&lng=es
Iparraguirre MF, Fajardo X, Carneiro E, Couto Souza PH. Desórdenes orales potencialmente malignos. Lo que el odontólogo debe conocer. Rev. Estomatol. Herediana. 2020;30(3):216-23. DOI: https://doi.org/10.20453/reh.v30i3.3826
Speight PM, Khurram SA, Kujan O. Oral potentially malignant disorders: risk of progression to malignancy. Oral Surg Oral Med Oral Pathol Oral Radiol. 2018;125(6):612-27. DOI: https://doi.org/10.1016/j.0000.2017.12.011
Tovío-Martínez EG, Carmona-Lorduy M, Díaz-Caballero AJ, Harris-Ricardo J, Lanfranchi-Tizeira HE. Expresiones clínicas de los trastornos potencialmente malignos en la cavidad oral. Revisión integrativa de la literatura. Univ Odontol. 2018;37(78):1-18. DOI: https://doi.org/10.11144/Javeriana.uo37-78.ecdp
Eccles K, Carey B, Cook R, Escudier M, Diniz-Freitas M, Limeres-Posse J, et al. Trastornos bucales potencialmente malignos: consejos de manejo en atención primaria. J Oral Med Oral Surg. 2022;28(36):[aprox. 9 p.]. DOI: https://doi.org/10.1051/mbcb/ 2022017
Gandara-Vila P, Pérez-Sayans M, Suárez-Peñaranda JM, Gallas-Torreira M, Somoza-Martín J, Reboiras-López MD, et al. Survival study of leukoplakia malignant transformation in a region of Northen Spain. Med Oral Pathol Oral Cir Oral. 2018;23(4):e413-e420. DOI: https://doi.org/10.10.4317/medoral.22326
Hernández-Pérez F, Rivera-Macías S. Leucoplasia homogénea de cavidad bucal. Oral. 2019 [acceso 04/09/2022];20(63):1723-26. Disponible en: https://www.medigraphic.com/pdfs/oral/ora-2019/ora1963d.pdf
Toledo-Cabarcos Y, Suárez-Sori B, Mesa-López A, Albornoz-López Castillo C. Clinical and histopathological description of oral leukoplakia. AMC. 2018 [acceso 08/12/2022];22(4):432-51. Disponible en: https://www.medigraphic.com/pdfs/medicocamaguey/amc/2018/amc184d.pdf
Palmerín-Donoso A, Cantero-Macedo AM, Tejero-Mas M. Leucoplasia bucal. Aten Primaria. 2019;52(1):59-60. DOI: https://doi.org/10.1016/j.aprim.2019.02.08
Araya C. Diagnóstico precoz y prevención en cáncer de cavidad oral. Rev. Med. Clin. CONDES. 2018;29(4):411-8. DOI: https://doi.org/10.1016/j.rmclc.2018.06.008
Batista-Castro Z, González-Aguilar V, García-Barceló MC, Rodríguez-Pérez I, Miranda-Tarragó JD, Chica-Padilla MA, et al. Evaluación clínico-epidemiológica de trastornos Estomatol. 2019 [acceso 08/12/2022];56(4):e1561-e72. Disponible en: http://revestomatologia.sld.cu/index.php/est/article/view/1561/16
Morales-Morán L, Lescay-Mevil Y, García-Romero J, Mayan-Reyna G. Displasia epitelial, en adulto mayor. Invest. Medicoquir. 2020 [acceso 08/12/2022];11(3):1-14. Disponible en: https://revcimeq.sld.cu/index.php/imq/article/view/537
Smith CJ, Renstrup G. The chronic inflammatory cell reactions associated with oral leukoplakia. Meeting Investigation Oral Pre-cancer. Bombay, La India. 1970.
Pindborg JJ, Reichart CJ. Who histological typing of cancer and precancer of the oral mucosa. New York: Springer; 1997.
Published
How to Cite
Issue
Section
License
Authors retain all rights to their works, which they can reproduce and distribute as long as they cite the primary source of publication.
The Rev Cubana Estomatol is subject to the Creative Commons Attribution-Non-Commercial 4.0 International License (CC BY-NC 4.0) and follows the publication model of SciELO Publishing Schema (SciELO PS) for publication in XML format.
You are free to:
- Share — copy and redistribute the material in any medium or format.
- Adapt — remix, transform, and build upon the material.
The licensor cannot revoke these freedoms as long as you follow the license terms.
Under the following terms:
Attribution — You must give appropriate credit, provide a link to the license, and indicate if changes were made. You may do so in any reasonable manner, but not in any way that suggests the licensor endorses you or your use.
- NonCommercial — You may not use the material for commercial purposes.
No additional restrictions — You may not apply legal terms or technological measures that legally restrict others from doing anything the license permits.
Notices:
- You do not have to comply with the license for elements of the material in the public domain or where your use is permitted by an applicable exception or limitation.
- No warranties are given. The license may not give you all of the permissions necessary for your intended use. For example, other rights such as publicity, privacy, or moral rights may limit how you use the material.